Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: Simvastatin, but not pravastatin, inhibits the proliferation of esophageal adenocarcinoma and squamous cell carcinoma cells: a cell-molecular study

Fig. 2

MDA production in Eca-109 and OE-19 cells treated with simvastatin or pravastatin. OE-19 and Eca-109 cells were treated with 0.1% DMSO or different doses (15 μM, 30 μM, 45 μM, 60 μM and 75 μM) of Simvastatin (a) or pravastatin (b) for 24 h. MDA levels were determined using TBA assay. * indicates significant difference from DMSO group (P < 0.05). MDA, Malondialdehyde; Eca-109, Esophageal squamous cell carcinoma; OE-19, esophageal adenocarcinoma; DMSO, dimethylsulfoxide; TBA, thiobarbituric acid

Back to article page